Multicenter, phase <scp>III</scp> trials on the contraceptive efficacy, tolerability and safety of a new drospirenone‐only pill

This is the first report of a new drospirenone-only oral contraceptive providing clinical efficacy similar to combined oral contraceptives, with a good safety profile, and favorable cycle control.